DRREDDY's weekly performance was lackluster, with a return of -1.13% and a Sharpe Ratio of -0.34, indicating poor risk-adjusted returns. The stock's volatility was moderate at 17.54%, but its Max Drawdown of -1.78% suggests a relatively high risk profile. Compared to peers, DRREDDY underperformed DIVISLAB and SUNPHARMA, but outperformed them in terms of volatility. However, it was significantly outperformed by HINDUNILVR. Overall, DRREDDY's weekly performance was disappointing and relatively risky.

[Volatility: 17.54%]